NCT07518329
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07518329
Title Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arovella Therapeutics Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.